secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001357874-25-000005
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences amends employment agreements with four top executives; adds escrow for severance
--------------------------------------------------------------------------------

- Amended agreements with CEO Michael Amoroso, CFO Alex Kelly, GC Dario Scimeca, and CRO Jeff Smith.
- Changes include current base salary, target bonus, lump-sum cash severance, and change-in-control/restructuring provisions.
- Cash severance and expenses must be funded in an escrow account with JPMorgan Chase; interest accrues to company.
- Unused funds return to Precision BioSciences; agreements are substantively similar to prior contracts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000135787425000005/0001357874-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000135787425000005/dtil-20250826.htm
  HTML page:      https://secwatch.observer/filing/0001357874-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer